The total trade value of SCO Member States has increased nearly 100 times over the past 20 years

China's First Oral COVID-19 Antiviral Medicine in Dispute

An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.

Unpacking China | Key Chinese Firms to Watch This Week （31/05/2026-06/06/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

ANTA (安踏) Becomes Global Strategic Partner of ZXMOTO (张雪机车), Launching Co-Branded Product Series

ANTA (安踏) has officially become the global strategic partner of ZXMOTO (张雪机车), celebrating the motorcycle brand's recent WSBK championships by simultaneously launching a co-branded sports apparel and footwear collection.

China's Smart Lawn Mower Exports Experience High-Speed Growth, Fueled by an Explosion in Overseas Demand for Wire-Free Robotic Solutions

China's robotic lawn mower segment is experiencing rapid export growth by shifting from traditional machinery to high-value intelligent hardware, driven by technological leaps in "wire-free" navigation that directly address high manual labor costs in mature Western markets.

Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab

The study data showed that compared to chemotherapy alone, toripalimab in combination with chemotherapy in the first-line treatment of patients with advanced NSCLC without EGFR/ALK mutations could significantly improve the PFS and the OS of patients with a manageable safety profile regardless of PD-L1 expression status.